Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011

Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011 IntroductionGout and rheumatoid arthritis (RA) are the 2 most common forms of inflammatory arthritis worldwide. As hospitalizations for both conditions lead to substantial health resource use, contemporary inpatient trends and associated costs may provide important benchmarks of disease burden. For example, a previous study during the prebiologic agent era found that hospital costs accounted for more than half of the total medical costs of RA . Indeed, varying levels of perceived success in care and changing epidemiology may have substantially impacted the hospitalization trends of RA and gout over the past decade. For example, new potent drugs (e.g., biologic agents), effective combination therapy, and management strategies (e.g., treating to target, early RA intervention) have become increasingly adopted for RA care ; however, whether these perceived improvements have been translated into a reduction in hospitalization rates and costs among RA patients in recent years is largely unknown. In contrast, despite the availability of effective pharmacologic options, gout management remains remarkably suboptimal, with a high rate of recurrent attacks . Further, the prevalence and incidence of gout have been increasing worldwide . Nevertheless, as in RA, whether these factors have translated to rising hospitalization trends among gout patients also remains unclear.BoxSignificance http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis Care and Research Wiley

Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011

Download PDF
5 pages

Loading next page...
 
/lp/wiley/trends-in-gout-and-rheumatoid-arthritis-hospitalizations-in-canada-Wly8oS63uR

References (20)

Publisher
Wiley
Copyright
© 2017, American College of Rheumatology
ISSN
2151-464X
eISSN
2151-4658
DOI
10.1002/acr.23012
pmid
27565008
Publisher site
See Article on Publisher Site

Abstract

IntroductionGout and rheumatoid arthritis (RA) are the 2 most common forms of inflammatory arthritis worldwide. As hospitalizations for both conditions lead to substantial health resource use, contemporary inpatient trends and associated costs may provide important benchmarks of disease burden. For example, a previous study during the prebiologic agent era found that hospital costs accounted for more than half of the total medical costs of RA . Indeed, varying levels of perceived success in care and changing epidemiology may have substantially impacted the hospitalization trends of RA and gout over the past decade. For example, new potent drugs (e.g., biologic agents), effective combination therapy, and management strategies (e.g., treating to target, early RA intervention) have become increasingly adopted for RA care ; however, whether these perceived improvements have been translated into a reduction in hospitalization rates and costs among RA patients in recent years is largely unknown. In contrast, despite the availability of effective pharmacologic options, gout management remains remarkably suboptimal, with a high rate of recurrent attacks . Further, the prevalence and incidence of gout have been increasing worldwide . Nevertheless, as in RA, whether these factors have translated to rising hospitalization trends among gout patients also remains unclear.BoxSignificance

Journal

Arthritis Care and Research – Wiley

Published: May 1, 2017

There are no references for this article.